3E0.F ESTABLISHMENT LABS HLDGS

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
59.88 EUR
Close of Nov 11, 2026
37.60 83.28
Market cap
EUR 1.79B
P/E
-
P/B
128.86x
ROE
-306.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 3E0.F undervalued?

Graham number

The Graham number of ESTABLISHMENT LABS HLDGS cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ESTABLISHMENT LABS HLDGS fundamental analysis

No fundamental analysis for ESTABLISHMENT LABS HLDGS yet.

ESTABLISHMENT LABS HLDGS stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ESTABLISHMENT LABS HLDGS

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales…

Full company profile